OpenTrons Labworks, Inc., founded in 2013 and based in the United States, operates within the manufacturing sector, specifically focusing on electronics, industrial automation, and biotechnology. The company specializes in developing automated laboratory solutions aimed at enhancing efficiency in clinical laboratory processes. Its expertise is particularly evident in the automation of next-generation sequencing (NGS) library preparation, as detailed in its published document on automating enzymatic fragmentation and library preparation using the Opentrons Flex robot. This document outlines a protocol that integrates multiple steps of the NGS library preparation process, allowing users to automate tasks such as DNA fragmentation, adapter ligation, and PCR amplification. By consolidating these steps into a single automated workflow, OpenTrons aims to minimize manual intervention, thereby conserving time for laboratory personnel. The company employs between 201 and 500 individuals and reported a revenue of approximately $58 million, indicating its established position within the manufacturing and biotechnology industries.